BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
ZBTB7A
,
calcium channel activity
,
Influenza
,
Hypothalamus
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
P4HA3;jsessionid=C4CF3F015FD72BEEE3B6B37273B712A7
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3.
P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway.
High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes.
Thrombospondin-1 and prolyl 4-hydroxylase subunit alpha 3 as potential biomarkers of salivary gland …
Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through th…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for P4HA3;jsessionid=C4CF3F015FD72BEEE3B6B37273B712A7
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ